tiprankstipranks

Louis Lange Insider Profile

4 Followers
Louis Lange, Director at CymaBay Therapeutics, holds 24.88K shares in NewAmsterdam Pharma Company (Ticker: NAMS), holds 0.00 shares in Audentes Therapeutics (Ticker: ~BOLD), holds 1.45K shares in CymaBay Therapeutics (Ticker: CBAY). Most recently, Louis Lange Bought ― shares of NewAmsterdam Pharma Company on Feb 21, 2024 for an estimated value of 95.00K.
tipranks
Louis Lange

Louis Lange
CymaBay Therapeutics (CBAY)
Director

Ranked #59,975 out of 99,335 Corporate Insiders

Profitable Transactions

33%
1 out of 3 Profitable Transactions

Average Return

-8.60%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$1M
51.06%
48.94%
0.00%
A breakdown of Louis Lange's holdings

Insider Roles

Esperion
(ESPR)
Director
NewAmsterdam Pharma Company
(NAMS)
Director
Gilead Sciences
(GILD)
Former EVP Cardio Therapeutics
Roles that Louis Lange holds in companies

Most Profitable Insider Trade

Stock:
NewAmsterdam Pharma Company
(NAMS)
Rating:Informative Buy
Date:Feb 21, 2024 - Today
Return:+11.80%
The most profitable trade made by Louis Lange

Louis Lange's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
CBAY
CymaBay Therapeutics
Oct 11, 2013
Uninformative Buy
$46.97K
~BOLD
Audentes Therapeutics
Jan 15, 2020
Uninformative Sell
18.92M
$0.00
NewAmsterdam Pharma Company
Feb 21, 2024
Director
Informative Buy
95.00K
$497.81K
Esperion
Jul 01, 2013
Director
Uninformative Buy
$519.40K
Gilead Sciences
Former EVP Cardio Therapeutics
$0.00
MAXY
Maxygen
List of latest transactions for each holding click on a transaction to see Louis Lange's performance on stock

Louis Lange insider profile FAQ

What is the percentage of profitable transactions made by Louis Lange?
The percentage of profitable transactions made by Louis Lange is 33%.
    What is the average return per transaction made by Louis Lange?
    The average return per transaction made by Louis Lange is -8.60%.
      What stocks does Louis Lange hold?
      Louis Lange holds: CBAY, ~BOLD, NAMS, ESPR, GILD, MAXY stocks.
        What was Louis Lange’s latest transaction?
        Louis Lange latest transaction was an Informative Buy of $95.00K.
          What was Louis Lange's most profitable transaction?
          Louis Lange’s most profitable transaction was an Informative Buy of NAMS stock on February 21, 2024. The return on the trade was 11.80%.
            What is Louis Lange's role in CymaBay Therapeutics?
            Louis Lange's role in CymaBay Therapeutics is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.